Gynecomastia: pathogenesis and approaches to treatment
Open Access
- 26 March 2025
- journal article
- Published by Endocrinology Research Centre in Bulletin of Reproductive Health
- Vol. 4 (1) , 32-38
Abstract
Gynecomastia is a benign enlargement of the breast glands in men that can be physiologic, pathologic, or idiopathic. Physiologic gynecomastia can occur in children and during puberty. Pathologic gynecomastia is associated with various endocrine, genetic disorders, systemic diseases, paraneoplastic processes, or may be iatrogenic. Common causes of pathologic gynecomastia are hypogonadism, testicular or adrenal tumors producing estrogens, androgen excess syndromes with aromatization, androgen deficiencies, hepatopathy, and nephropathy. Most commonly, the underlying cause of gynecomastia is an imbalance between estrogens and androgens. It is known that the treatment of syndromes causing gynecomastia depends on the etiology and pathogenesis, but gynecomastia itself is eliminated, as a rule, surgically. The use of drug therapy for gynecomastia is debated. It would probably be appropriate in cases of gynecomastia due to an imbalance between estrogens and androgens, given the initial stage of gynecomastia development. The main candidates for drug treatment of gynecomastia are anti-estrogens and aromatase inhibitors. These aspects are discussed in the review.Keywords
This publication has 48 references indexed in Scilit:
- Infant body composition: A comprehensive overview of assessment techniques, nutrition factors, and health outcomesNutrition in Clinical Practice, 2023
- Gynecomastia and psychological functioning: A review of the literatureBody Image, 2015
- Gynecomastia and drugs: a critical evaluation of the literatureEuropean Journal of Clinical Pharmacology, 2015
- Adrenocortical carcinoma: Past, present, and futureJournal of Surgical Oncology, 2012
- Establishment of Normative Data for the Amount of Breast Tissue Present in Healthy Children up to Two Years of AgeJournal of Pediatric and Adolescent Gynecology, 2010
- Management of physiological gynaecomastia with tamoxifenThe Breast, 2004
- Mechanism of feminization in male patients with non-alcoholic liver cirrhosis: Role of sex hormone-binding globulinGastroenterologia Japonica, 1991
- Alcohol-induced hypogonadism: Reversal after ethanol withdrawalDrug and Alcohol Dependence, 1987
- Gynecomastia in a hospitalized male populationThe American Journal of Medicine, 1984
- The estrogenic and antiestrogenic activities of androgens in female target tissuesPharmacology & Therapeutics, 1983